Top Markets
#1 Black Phoenix Black Phoenix +826.11%
#2 pipedog pipedog +30.60%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.23%
#4 SAFEcoin SAFEcoin +25.88%
#5 Beam Beam +22.88%
#6 PondCoin PondCoin +22.65%
#7 Bless Bless +21.86%
#8 Magma Finance Magma Finance +20.15%
#9 Prom Prom +17.56%
#10 YFSX YFSX +15.96%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Jinyu Bio-technology Co., Ltd. Jinyu Bio-technology Co., Ltd.

Jinyu Bio-technology Co., Ltd.

600201
Rank in Stocks #6431
Based in Hohhot, China, Jinyu Bio-technology Co., Ltd. is a Chinese firm... Based in Hohhot, China, Jinyu Bio-technology Co., Ltd. is a Chinese firm specializing in the development, production, and commercialization of biological products for animal health. Established in 1992, the company provides crucial vaccines designed to combat diseases such as foot-and-mouth disease, highly pathogenic avian influenza, brucellosis, rabies, and swine fever. These vital immunizations are supplied for a broad spectrum of animals, including pigs, poultry, ruminants, and companion pets. The entity formally adopted its current name, Jinyu Bio-technology Co., Ltd., in December 2015, having previously operated as Inner Mongolia Jinyu Group Co., Ltd.
Share Price
$1.85
Market Cap
$2.05B
Change (1 day)
0.63%
Change (1 year)
51.64%
Country
CN
Trade Jinyu Bio-technology Co., Ltd. (600201)

Category

Healthcare
Revenue for Jinyu Bio-technology Co., Ltd. (600201)
Revenue in Aug 2026 TTM: 0
According to Jinyu Bio-technology Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Jinyu Bio-technology Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH